online casino 888

10 popular public high schools in New Jersey one can consider for quality education

Israel claims responsibility for Hamas leader's killing

In their fifth Europa League match of 2024-25, Portuguese side Braga will host Bundesliga team Hoffenheim at Estadio Municipal de Braga on Thursday. The Portuguese side are 26th in the Europa League table with four points and drew 1-1 with Elfsborg on November 7, while their opponents drew 2-2 with Lyon on the same date and are 19th with five points. © Imago Braga were dominant in the first half against Elfsborg considering they accumulated 66% possession and created two big chances in the opening 45 minutes, but though they eventually took the lead 67th minute, Elfsborg managed to net an equaliser in the 84th minute. While boss Carlos Carvalhal will be disappointed by the draw, he will at least take comfort from the fact his team are only behind 24th-placed Elfsborg, who occupy the final round of 16 playoff spot, due to goal difference. Carvalhal's side are currently fifth in the Primeira Liga with 20 points from 11 games, and their record of 19 goals scored and 11 conceded makes them the division's fourth best offensive and joint fifth best defensive club. The Archbishops have won one, drawn one and lost one of their three most recent matches, and have failed to achieve victory in any of their past three outings in the Europa League. Braga's home record has been strong in recent weeks, with the Portuguese side having triumphed in six of their last nine fixtures at Estadio Municipal de Braga. © Imago Opponents Hoffenheim come into the clash off the back of a thrilling 4-3 win against RB Leipzig on November 23, a match in which they trailed 1-0, 2-1 and 3-1 but scored a winner in the 87th minute. The result will have been particularly welcomed by manager Christian Ilzer given his team's game against Die Roten Bullen was his first in charge of the club. Die Kraichgauer are 13th in the Bundesliga with 12 points after 11 matchweeks, and the victory against third-placed Leipzig was just their third in the top flight. Hoffenheim are unbeaten in their last three games having drawn two and won one, and have achieved victory in one, drawn two and been defeated in one of their past four Europa League fixtures. Ilzer will have to hope he can turn around his team's fortunes on the road considering they are winless in their last seven outings away from home, drawing four and losing three. In fact, Hoffenheim have lost 12, drawn six and won just three of their past 21 away fixtures. © Imago Braga's only confirmed injury absentee is midfielder Rodrigo Zalazar, who will not make an appearance until early next month, so perhaps Carvalhal will select a double pivot consisting of Vitor Carvalho and Joao Moutinho . In defence, Braga are almost certain to persist with a back three, and centre-backs Joao Ferreira , Paulo Oliveira and Bright Arrey-Mbi are candidates to start. As for Hoffenheim, they will be without a number of players including defenders Christopher Lenz , Florian Grillitsch and Ozan Kabak . In their absence, expect Pavel Kaderabek , Arthur Chaves , Stanley N'Soki and Alexander Prass to be chosen to protect goalkeeper Oliver Baumann . Midfielders Grischa Promel and Finn Becker will also miss out, and this could mean Anton Stach and Tom Bischof partner each other again in the centre of the pitch, just as they did against Leipzig. Adam Hlozek , Andrej Kramaric , Mergim Berisha and Haris Tabakovic may start in attack considering forwards Ihlas Bebou , Marius Bulter and Max Moerstedt are not scheduled to return until later in December. Braga possible starting lineup: Hornicek; Ferreira, Oliveira, Arrey-Mbi; Fernandes, Carvalho, Moutinho, Martinez; Horta, Gharbi, Fernandez Hoffenheim possible starting lineup: Baumann; Kaderabek, Chaves, N'Soki, Prass; Stach, Bischof; Hlozek, Kramaric, Berisha; Tabakovic Given Braga have been strong at home, it is difficult to see them succumbing to defeat on Thursday, and the hosts will feel they can target the visitors' vulnerable defence. However, Hoffenheim will be full of confidence following their win last time out and it would not be surprising if they managed to earn a point. For data analysis of the most likely results, scorelines and more for this match please click here .Syra Health to Present at NobleCon20

BOULDER, Colo. (AP) — Nyla Harris had 14 points and Jayda Curry scored 10 of her 14 points in the fourth quarter to help No. 24 Louisville get past Colorado 79-71 on Saturday. The Cardinals led 56-55 after three quarters before pulling away in the fourth by scoring 16 unanswered points, capped by a fast-break layup by Curry, before Colorado made its first field goal of the frame with 2:48 left. Colorado scored the next six points to get within single digits at 72-63, but freshman Tajianna Roberts banked in a jumper in the lane at the other end. Izela Arenas sealed it on two free throws with 24.9 seconds left for a nine-point lead. Roberts finished with 13 and Arenas had 11 for Louisville (5-2). Frida Formann scored 25 points for Colorado (6-2). Jade Masogayo added 12 points, Nyamer Diew scored 10 and Kindyll Wetta matched her career-high with 10 assists. Formann went on a personal 8-0 run to give Colorado a 43-37 lead with 7:38 left in the third. She reached 20 points during the run, while no other player had scored in double figures. Louisville plays No. 8 Oklahoma on Wednesday in the SEC/ACC Challenge. Colorado continues a five-game homestand against Tennesse Tech on Tuesday. ___ Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP women’s college basketball: https://apnews.com/hub/ap-top-25-womens-college-basketball-poll and https://apnews.com/hub/womens-college-basketball

NDP will not support Liberal GST holiday bill unless rebate expanded: Singh

On a rare two-game skid, No. 24 Arizona faces Davidson

HAYWARD, Calif.--(BUSINESS WIRE)--Dec 23, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field AblationTM (nano-PFA or nsPFATM) technology, today announced that it intends to deliver an irrevocable notice of redemption, on or about December 27, 2024, to redeem the first tranche of common stock warrants, redeemable by the Company if the Company’s stock trading price exceeds $16.50 for twenty consecutive trading days, that were issued as part of its July 3, 2024 rights offering which are still outstanding as of February 5, 2025 (the “Redemption Date”). These outstanding common stock warrants (the “150% Warrants”), which were issued in the Company’s 2024 rights offering (the “Rights Offering”), pursuant to the Company’s Registration Statement on Form S-3, as amended (File No. 333-278494), may be exercised by the holders thereof until 6:30 p.m., Eastern time, on the Redemption Date, at the exercise price of $11.00 per share of Company common stock, $0.001 par value per share. Any 150% Warrants not exercised before 6:30 p.m., Eastern time, on February 5, 2025, will be redeemed by the Company for $0.01 per 150% Warrant share (the “Redemption Price”). Under the terms of the 150% Warrants, the Company has the right to redeem the 150% Warrants (CUSIP # 74587B135) if the volume weighted average price (as defined therein, “VWAP”) exceeds $16.50 per share for twenty (20) consecutive trading days at least three months after the date that the 150% Warrants were issued. This requirement was met for each of the twenty consecutive trading days preceding December 23, 2024. Over this period, the Company had an average VWAP of $18.85. Any 150% Warrants that remain unexercised at 6:30 p.m., Eastern time, on the Redemption Date, will be void and no longer exercisable, and the holders of those 150% Warrants will be entitled to receive only the Redemption Price of $0.01 per 150% Warrant share. The second tranche of common stock warrants issued in the Rights Offering (the “200% Warrants”) are not being redeemed at this time. The Company received aggregate gross proceeds of $60 million from its Rights Offering, which was completed in July 2024, and the Company will receive an additional $66 million of gross proceeds, if all of the 150% Warrants and all of the 200% Warrants (collectively, the “Warrants”) are exercised prior to the Redemption Date. None of the Company, its board of directors or employees has made or is making any representation or recommendation to any holder of any Warrants as to whether to exercise or refrain from exercising any Warrants. A registration statement, as amended, relating to the Rights Offering was previously filed with the Securities and Exchange Commission (the “SEC”) and declared effective on May 31, 2024. A prospectus relating to the offering was filed with the SEC on and supplemented on June 4, 2024 and is available on the SEC’s website. The Company will post a copy of the notice of redemption being sent to the holders of the 150% Warrants on its investor relations website at investors.pulsebiosciences.com . Questions concerning redemption and exercise of the 150% Warrants can be directed to Broadridge Corporate Issuer Solutions, LLC, Attn: BCIS Re-Organization Dept., P.O. Box 1317, Brentwood, NY 11717-0718, telephone number 888-789-8409 or to shareholder@broadridge.com . No Offer or Solicitation This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. About Pulse Biosciences® Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFATM technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. Pulse Biosciences is now headquartered in Miami, Florida and maintains its office in Hayward, California. Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries. Forward-Looking Statements All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company’s planned redemption of outstanding warrants, statements concerning its expected product development efforts, statements about its Nanosecond Pulsed Field Ablation (nsPFA) technology to non-thermally clear cells while sparing adjacent noncellular tissue, as well as statements concerning customer adoption and future use of the CellFX System to address a range of conditions such as atrial fibrillation. These statements are not historical facts but rather are based on Pulse Biosciences’ current expectations, estimates, and projections regarding Pulse Biosciences’ business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Pulse Biosciences’ control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Pulse Biosciences’ filings with the Securities and Exchange Commission. Pulse Biosciences undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available. View source version on businesswire.com : https://www.businesswire.com/news/home/20241223275716/en/ CONTACT: Investor Contacts: Pulse Biosciences Darrin Uecker, CTO or Kevin Danahy, CCO IR@pulsebiosciences.com or Gilmartin Group Philip Trip Taylor 415.937.5406 philip@gilmartinir.com KEYWORD: CALIFORNIA FLORIDA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL DEVICES HEALTH PHARMACEUTICAL CARDIOLOGY SOURCE: Pulse Biosciences, Inc. Copyright Business Wire 2024. PUB: 12/23/2024 04:30 PM/DISC: 12/23/2024 04:30 PM http://www.businesswire.com/news/home/20241223275716/enAries : This is a time of discovery. You will have a desire to get out of your comfort zone and get new experiences. Look to update your skills and strive for certifications that may help you climb your career ladder. Do not argue with co-workers, and instead, focus on selling ideas with confidence. December’s energy is favourable for people who are willing to take risks in their careers. However, this month is not especially lucky when it comes to love. Do not rush into new relationships, as misunderstandings may arise. Taurus : Think about the areas of your life that require change, release, and creating a healthier emotional and financial environment. In terms of your career, this month will be a mixed bag. Candidates may get annoyed by such actions as postponing the interviews or cases where the employer is unclear about what they want. This is a good time to review insurance policies, wills, and long-term financial plans. Purchases of real estate or vehicles may be further discussed before the final decision is made. Gemini : This month’s energy challenges you to assess how effectively you collaborate and build the stability of your connections. This is a good time for singles to find that special someone through friends, business acquaintances or at work. For the committed, a discussion about the future is always useful and can make you and your partner see things in the same way. Concerning career, do not take all the work to yourself; it will be more productive if the work is divided. Networking will be especially useful this month. Cancer : The month is about maintaining order and tidiness and solving any problems that may still remain to hinder your progress. This is a time to deal with work assignments and demonstrate how well you can handle projects. Be careful with details because small errors can cause bigger problems. You may get involved in helping a family member deal with some difficulties. This may feel overwhelming, but it will enhance the relationships. If you have neglected health symptoms, now is the time to seek advice. Leo : You may need self-assertion and a wish to be noticed both in private and working life. However, moderation is the word when it comes to enthusiasm because it can lead to hasty decision-making. In your career, this is a month of creativity and risk-taking. A balance between creativity and business-mindedness will lead to desirable outcomes. If you are thinking about investing in real estate or the stock market, it is the right time to consider long-term goals. Singles will gain attention due to their charm and energetic personality. Virgo : This month may make you want to create balance in your private life. For those working, the focus should be on managing working responsibilities with other obligations. Financially, this is a good time to invest in real estate, though make sure to read the contract carefully. This is a favourable period for family gatherings and conversations, especially those concerning property or work division. If you are a student, this period is beneficial for research and courses that need a systematic approach. Libra : It is a month where you get a chance to learn new things through asking questions and making efforts. You may feel more confident in expressing yourself and participating in activities that make you better. In your career, it is the time to demonstrate your communication skills and foster good working relationships with your colleagues or clients. Those who are interested in writing, speaking, or social activities may get a job in public relations, sales or teaching. For those who are in love, this deepens the relationship through short trips. Scorpio : It’s the time to focus on your budget, work on your interpersonal skills, and be consistent with your behaviours in achieving your life goals. Financially, December is all about stability and planning. This is a good time to take stock of your financial position, be prudent in your spending, and consider your investment options. Discussions with parents or siblings regarding issues related to property, money or any future plans may come up. Cold weather may increase your likelihood of developing throat problems. Sagittarius : The month challenges you to own your life, improve yourself, and create momentum for the year. You will be full of energy and ready to chase your goals, but it is advisable to combine this energy with planning. At work, take the lead on projects that showcase your talents. Single people can get attention without any problem, and it is possible to meet someone who will be a powerhouse of energy. Family life will be pleasant this month as you will lead the people around you with a positive attitude. Capricorn : It is a time for relaxation, rejuvenation and shedding off all the troubles of the past. This time may be less social than usual, but it is a good chance to get some perspective and set goals. In your career this month, you may need patience and work in the background. Do not take risks this month because the energy is more suitable for steady growth than grand gestures. It is not advised to make large purchases or invest during this period. Take care of your health because stress can cause you to feel tired. Aquarius : December is a month of opportunities and recognition in your career. You can get a job through referral, hence the need to maintain a connection with your network. This is a good moment to assume leadership positions. Your skills to mobilise people and engage them towards a common cause will define you. Stock investments may bear fruit, especially if they are associated with technology-based industries. For singles, this is a time to find a partner through social or business-related contacts. Pisces : This is a month in your career where you can reap big if you put more effort and concentration. This is a time to be proactive and show your worth at the workplace. One will be able to effectively coordinate tasks and deal with issues that will earn the respect of supervisors and peers. In love, the stars make you loyal and committed to the person you are in a relationship with. Those who are single may get attracted to people who are focused and ambitious. Work commitments may overshadow your family time. ---------------------- Neeraj Dhankher (Vedic Astrologer, Founder - Astro Zindagi) Email: info@astrozindagi.in , neeraj@astrozindagi.in Url: www.astrozindagi.in Contact: Noida: +919910094779

Advisors Asset Management Inc. decreased its position in B&G Foods, Inc. ( NYSE:BGS – Free Report ) by 45.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,724 shares of the company’s stock after selling 10,401 shares during the quarter. Advisors Asset Management Inc.’s holdings in B&G Foods were worth $113,000 as of its most recent SEC filing. A number of other institutional investors and hedge funds have also modified their holdings of the company. Innealta Capital LLC bought a new position in B&G Foods in the 2nd quarter worth $33,000. nVerses Capital LLC bought a new position in shares of B&G Foods in the second quarter worth about $33,000. Versant Capital Management Inc lifted its position in shares of B&G Foods by 36.9% during the 2nd quarter. Versant Capital Management Inc now owns 5,768 shares of the company’s stock worth $47,000 after purchasing an additional 1,555 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in B&G Foods by 1,556.9% during the 1st quarter. Russell Investments Group Ltd. now owns 4,921 shares of the company’s stock valued at $56,000 after purchasing an additional 4,624 shares during the period. Finally, LRI Investments LLC acquired a new stake in B&G Foods in the 1st quarter valued at approximately $60,000. 66.15% of the stock is currently owned by institutional investors and hedge funds. Analyst Ratings Changes A number of research analysts have recently commented on BGS shares. Evercore ISI cut their price target on B&G Foods from $10.00 to $9.00 and set an “in-line” rating for the company in a report on Wednesday, November 6th. StockNews.com raised shares of B&G Foods from a “sell” rating to a “hold” rating in a research report on Thursday, September 26th. Royal Bank of Canada reissued a “sector perform” rating and issued a $10.00 price target on shares of B&G Foods in a report on Wednesday, August 7th. Barclays dropped their price objective on shares of B&G Foods from $8.00 to $7.00 and set an “equal weight” rating on the stock in a report on Thursday, November 7th. Finally, TD Cowen reduced their target price on shares of B&G Foods from $8.00 to $7.50 and set a “sell” rating for the company in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating and five have given a hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $8.30. Insider Transactions at B&G Foods In related news, EVP Eric H. Hart purchased 5,000 shares of the stock in a transaction on Friday, November 15th. The shares were purchased at an average cost of $6.25 per share, for a total transaction of $31,250.00. Following the completion of the transaction, the executive vice president now directly owns 88,899 shares of the company’s stock, valued at approximately $555,618.75. The trade was a 5.96 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website . Also, Director Stephen Sherrill acquired 70,000 shares of the business’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $6.63 per share, with a total value of $464,100.00. Following the completion of the acquisition, the director now owns 353,084 shares of the company’s stock, valued at approximately $2,340,946.92. This trade represents a 24.73 % increase in their position. The disclosure for this purchase can be found here . In the last ninety days, insiders purchased 90,111 shares of company stock valued at $593,054. Corporate insiders own 3.20% of the company’s stock. B&G Foods Price Performance BGS opened at $6.68 on Friday. The company has a market capitalization of $528.82 million, a P/E ratio of -19.65 and a beta of 0.61. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.64 and a quick ratio of 0.49. The firm’s fifty day moving average price is $7.82 and its two-hundred day moving average price is $8.34. B&G Foods, Inc. has a fifty-two week low of $6.12 and a fifty-two week high of $11.97. B&G Foods ( NYSE:BGS – Get Free Report ) last issued its earnings results on Tuesday, November 5th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.07). B&G Foods had a negative net margin of 1.34% and a positive return on equity of 6.97%. The business had revenue of $461.10 million for the quarter, compared to analyst estimates of $473.82 million. During the same quarter last year, the firm posted $0.27 earnings per share. B&G Foods’s revenue was down 8.3% on a year-over-year basis. On average, analysts anticipate that B&G Foods, Inc. will post 0.73 EPS for the current year. B&G Foods Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Thursday, January 30th. Stockholders of record on Tuesday, December 31st will be issued a $0.19 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 11.38%. B&G Foods’s payout ratio is presently -223.53%. B&G Foods Company Profile ( Free Report ) B&G Foods, Inc manufactures, sells, and distributes a portfolio of shelf-stable and frozen foods, and household products in the United States, Canada, and Puerto Rico. The company's products include frozen and canned vegetables, vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, maple syrups, molasses, salad dressings, pizza crusts, Mexican-style sauces, dry soups, taco shells and kits, salsas, pickles, peppers, tomato-based products, crackers, baking powder and soda, corn starch, nut clusters, and other specialty products. Further Reading Five stocks we like better than B&G Foods How to Buy Cheap Stocks Step by Step The Latest 13F Filings Are In: See Where Big Money Is Flowing Upcoming IPO Stock Lockup Period, Explained 3 Penny Stocks Ready to Break Out in 2025 How to invest in marijuana stocks in 7 steps FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Want to see what other hedge funds are holding BGS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for B&G Foods, Inc. ( NYSE:BGS – Free Report ). Receive News & Ratings for B&G Foods Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for B&G Foods and related companies with MarketBeat.com's FREE daily email newsletter .KORE Announces NYSE Acceptance of Plan to Regain Listing Compliance

None

Oklahoma State's 3-point accuracy sends Miami to defeatSpotswood closes strong to defeat East Brunswick - Girls basketball recap

Previous: gambit city online casino
Next: online casino baccarat